MedMira Inc (TSXV: MIR), a developer of rapid testing technologies and solutions, is featured as today’s top momentum gainer since it gained over 20% touching its new intraday 52-week highs during the last two consecutive trading days with far more shares changing hands than in a normal session. During the last trading session, MIR was the top gainer in the Canadian healthcare space after rising 44.4% and closed at its 52-week high of C$0.13 while recording huge volumes of over 1.5 million shares. During the past 5 trading sessions, MIR skyrocketed over 73% with 5-day daily average traded volumes of 0.6 million shares. A strong momentum is witnessed in the stock since it has surged 117% in the past one month with daily average volume of 0.3 million shares. On January 13, 2014, the company announced a U.S. distribution agreement with VWR International LLC, a global solutions provider of laboratory supplies and services. MedMira will benefit from the breadth of VWR’s experience in reaching various U.S. industries including research, education and healthcare. VWR is selling MedMira’s Miriad platform technology as well as its Reveal G3 rapid HIV test. In the future, MedMira and VWR will expand more rapid testing products to its portfolio.
Company Description:
MedMira Inc. (TSXV: MIR) is a medical biotechnology company that develops, manufactures, and markets a new generation of rapid diagnostic tests and instrumentation. The company’s products aid in the diagnosis of both infectious and non-infectious human diseases. MedMira’s products are marketed worldwide.
1-Year Stock Chart:
Source: Bloomberg
